Patient characteristicsa (n = 10)

PatientAge (yr)SexWt (kg)SOFA scoreTemp (°C)Pump speed (LPM)Centrifugal pump speed (RPM)Sweep gas flow (LPM)Heparin dose (IE/h)CRRTMicrobiologybAmt of:
P-creatinine (μmol/liter)Bilirubin (μmol/liter)Albumin (g/liter)
158F91837.03.722,9554.5500YesIFV A11331727
230F55935.93.422,6603.5200YesIFV A11291239
359M1151336.14.703,3005.0700YesS. pneumoniae1179631
448M80936.44.573,0007.02,000YesIFV A,1 galactomannan2671021
559M1011336.34.763,3553.0600YesIFV A,1 S. maltophilia32223629
646F1341036.44.113,9304.5600YesIVF A,1 C. pneumoniae42171432
754M1021536.35.313,6007.5500YesIVF A,2 S. haemolyticus,3 enterococcus512813129
869M100436.94.553,2004.01,600NoS. pneumoniae2771622
965F801336.64.653,1806.01,600YesS. pneumoniae2,41292420
1048M1151336.84.403,2006.51,500YesIVF A,1 A streptococcus3,43539016
  • a All data were registered on day 1. Abbreviations: SOFA score, sequential organ failure assessment score; LPM, liters per minute; RPM, revolutions per minute; CRRT, continuous renal replacement therapy; F, female; M, male; IFV A, influenza A virus; S. pneumoniae, Streptococcus pneumoniae; galactomannan, aspergillus galactomannan; C. pneumoniae, Chlamydophila pneumoniae; S. haemolyticus, Staphylococcus haemolyticus; A streptococcus, group A streptococcus.

  • b Origins of the pathogens are indicated by superscript numbers: 1, sputum; 2, bronchoalveolar lavage; 3, respiratory secretions; 4, blood; 5, scrotal skin.